These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4852725)

  • 1. Letter: Circular dichroism study on inclusion complexes of beta-cyclodextrin with anti-inflammatory fanamates.
    Ikeda K; Uekama K; Otagiri M; Hatano M
    J Pharm Sci; 1974 Jul; 63(7):1168-9. PubMed ID: 4852725
    [No Abstract]   [Full Text] [Related]  

  • 2. Flow-injection spectrofluorimetric determination of flufenamic and mefenamic acid in pharmaceuticals.
    Albero MI; Sanchez-Pedreño C; Garcia MS
    J Pharm Biomed Anal; 1995 Aug; 13(9):1113-7. PubMed ID: 8573636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of flufenamic acid, its derivatives and analogous compounds].
    Dell HD; Kamp R
    Arch Pharm Ber Dtsch Pharm Ges; 1970 Oct; 303(10):785-91. PubMed ID: 5275816
    [No Abstract]   [Full Text] [Related]  

  • 4. Human metabolism of tolfenamic acid. II. Structure of metabolites and C-13 NMR assignments of fenamates.
    Khalifah RG; Hignite CE; Pentikäinen PJ; Penttilä A; Neuvonen PJ
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):269-76. PubMed ID: 7166179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental observations on flufenamic, mefenamic, and meclofenamic acids. I. Pharmacology.
    Winder CV
    Ann Phys Med; 1966; Suppl():7-16. PubMed ID: 6004862
    [No Abstract]   [Full Text] [Related]  

  • 6. Capillary isotachophoretic determination of flufenamic, mefenamic, niflumic and tolfenamic acid in pharmaceuticals.
    Polásek M; Pospísilová M; Urbánek M
    J Pharm Biomed Anal; 2000 Aug; 23(1):135-42. PubMed ID: 10898163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution behavior of polymorphs of chloramphenicol palmitate and mefenamic acid.
    Aguiar AJ; Zelmer JE
    J Pharm Sci; 1969 Aug; 58(8):983-7. PubMed ID: 5344535
    [No Abstract]   [Full Text] [Related]  

  • 8. Spectrophotometric method for the determination of flufenamic and mefenamic acids.
    Aboul Khier A; el-Sadek M; Baraka M
    Analyst; 1987 Oct; 112(10):1399-403. PubMed ID: 3434820
    [No Abstract]   [Full Text] [Related]  

  • 9. Inclusion complexation of barbiturates with beta-cyclodextrin in aqueous solution. I. Spectroscopic study on the mode of interaction.
    Otagiri M; Miyaji T; Uekama K; Ikeda K
    Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1146-54. PubMed ID: 1021280
    [No Abstract]   [Full Text] [Related]  

  • 10. pH-induced difference spectrophotometric methods for drug analysis. Part 2: Determination of mefenamic and flufenamic acid.
    Hassan SM; Shaaban SA
    Pharmazie; 1984 Oct; 39(10):691-3. PubMed ID: 6522446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of mefenamic acid and flufenamic acid on plasma uric acid levels.
    Latham BA; Radcliff F; Robinson RG
    Ann Phys Med; 1966 Aug; 8(7):242-3. PubMed ID: 5918265
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical properties of anti-inflammatory drugs. X. The inhibition of serotonin formation in vitro and inhibition of the esterase activity of alpha-chymyotrypsin.
    Skidmore IF; Whitehouse MW
    Biochem Pharmacol; 1967 May; 16(5):737-51. PubMed ID: 6036725
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of mefenamic acid and flufenamic acid in clinical pain.
    Ferris JE; Pigott PV
    Ann Phys Med; 1966; Suppl():84-6. PubMed ID: 4895009
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical properties of anti-inflammatory drugs. XI. Structure-action relationship for the uncoupling of oxidative phosphorylation and inhibition of chymotrypsin by N-substituted anthranilates and related compounds.
    Whitehouse MW
    Biochem Pharmacol; 1967 May; 16(5):753-60. PubMed ID: 6036726
    [No Abstract]   [Full Text] [Related]  

  • 15. Physicochemical properties and uncoupling activity of 3'-substituted analogues of N-phenylanthranilic acid.
    Terada H; Muraoka S
    Mol Pharmacol; 1972 Jan; 8(1):95-103. PubMed ID: 5061521
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-blind evaluation of the analgesic and toxic effects of flufenamic acid and mefenamic acid in patients with chronic pain.
    Kater RM
    Med J Aust; 1968 May; 1(20):848-51. PubMed ID: 5652895
    [No Abstract]   [Full Text] [Related]  

  • 17. Antagonism by mefenamic and flufenamic acids of the bronchoconstrictor action of kinins in the guinea-pig.
    COLLIER HO; SHORLEY PG
    Br J Pharmacol Chemother; 1963 Apr; 20(2):345-51. PubMed ID: 14022332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANTI-INFLAMMATORY AND ANTIPYRETIC PROPERTIES OF N-(2,6-DICHLORO-M-TOLYL)ANTHRANILIC ACID (CI-583).
    WINDER CV; WAX J; WELFORD M
    J Pharmacol Exp Ther; 1965 Jun; 148():422-9. PubMed ID: 14334278
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analytical reactions of mefenamic and flufenamic acids].
    Devaux G; Mesnard P; Brisson AM
    Ann Pharm Fr; 1969 Mar; 27(3):239-48. PubMed ID: 5400246
    [No Abstract]   [Full Text] [Related]  

  • 20. The fibrinolytic activity of anti-inflammatory drugs.
    Gryglewski R
    J Pharm Pharmacol; 1966 Jul; 18(7):474. PubMed ID: 4381731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.